Ensign Peak Advisors, Inc
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$154,172
+$4,713 QoQ
Shares Held
9,085
-9.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#201
of 279 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. AUPH ranks #108 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in AUPH
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,172 | 9,085 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $149,459 | 10,085 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $160,855 | 10,085 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $362,826 | 32,835 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $539,835 | 63,735 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $512,429 | 63,735 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $572,340 | 63,735 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $467,177 | 63,735 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $363,926 | 63,735 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $319,312 | 63,735 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $601,880 | 66,950 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $381,507 | 49,100 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $343,156 | 35,450 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $301,928 | 40,150 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $328,735 | 32,710 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $404,949 | 32,710 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $710,570 | 31,070 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,903,522 | 131,203 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,964,723 | 151,599 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,312,251 | 101,059 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,291,127 | 93,357 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,009,373 | 68,525 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $254,361 | 15,653 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||